neurologic disorders
COVID Related Neuropsychiatric Manifestations
Treatment of COVID Related Neuropsychiatric Manifestations
Supportive care Sometimes antidepressants For most neuropsychiatric sequelae of COVID-19, supportive care is the main intervention. A comprehensive multidisciplinary approach aimed at the optimal management of comorbid conditions in patients with long COVID is important. For patients with depression or anxiety, controlled trials of treatments are lacking. However, because select serotonin-reuptake inhibitors (SSRIs) and serotonin-norepinephrinereuptake inhibitors (SNRIs) have anti-inflammatory properties, these drugs are hypothesized to ameliorate the inflammatory state accompanying COVID-19 as well as the co-existing depressive disorder. 